SEC restatements
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
BRAINSTORM CELL THERAPEUTICS INC. has 6 revised figures in later SEC filings: annual figures whose value in a later filing differs from the value on record first. Each revision below links to both filings.
CIK 0001137883
Most recent revisions
Newest 3 of 6 · as filed · by the latest filing stating each revision
| Figure | On record first | Revised |
|---|---|---|
| Shares outstandingPeriod ended Mar 28, 2019 | 29.49M sharesFiled Mar 29, 2019 (opens EDGAR in a new tab) | 21.49M sharesFiled Apr 1, 2019 (opens EDGAR in a new tab) |
| Operating incomePeriod ended Dec 31, 2014 | $-9.25MFiled Mar 26, 2015 (opens EDGAR in a new tab) | $-7.42MFiled Mar 9, 2016 (opens EDGAR in a new tab) |
| Current liabilitiesPeriod ended Dec 31, 2012 | $1.14MFiled Mar 14, 2013 (opens EDGAR in a new tab) | $1.16MFiled Mar 27, 2014 (opens EDGAR in a new tab) |
A revised figure is not by itself a correction of an error. Companies re-present prior figures for ordinary reasons too, such as a discontinued business, a merger or a new accounting standard. The value on record first is the earliest filing we hold that states the figure; the revised value is the latest revised value on record, linked to the latest filing that states it.
revised annual figures for BRAINSTORM CELL THERAPEUTICS INC.
This page shows the most recent 3. The complete list, every revised figure with both values and both filings, is in the API and the MCP server (get_revisions) on the Analyst plan.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- Every revised figure for this company, with both values and both filings (Analyst)
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/revisions/BCLI
MCP tool:
get_revisions ticker=BCLI
Not investment advice. Figures are shown as filed with the SEC; each one links to the filing it came from.